EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Temporal Changes in Alzheimer's Disease‐Related Biomarkers in the CSF of Cognitively Normal Subjects at Different Ages: The Chongqing Ageing and Dementia Study

Wei-Wei Li, Dong-Yu Fan, Qi Sun, Lei-Kai Wang, Bing-Qiang Huang, Zhong-Yuan Yu, Ding-Yuan Tian, Ying-Ying Shen, Cheng-Rong Tan, Gui-Hua Zeng, Fan Zeng, Jin Fan und 3 weitere

Aging Cell · 2025

DOI: 10.1111/acel.70036 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging Cell, 2025. Verfasst von Wei-Wei Li und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Centre for Clinical Neuroscience, Daping Hospital, Third Military Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Biomarkers, Alzheimer Disease, Aging, Cognition. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Joint Fund of Chongqing Health Commission and Chongqing Science and Technology Bureau, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Revealing the temporal evolution of cerebrospinal fluid (CSF) biomarkers during aging is critical to understanding disease pathogenesis and developing early diagnoses and interventions for Alzheimer's disease (AD). CSF was obtained from 549 cognitively normal subjects between 18 and 93 years of age. 12 AD‐related biomarkers were evaluated, including amyloid β (Aβ42, Aβ40, Aβ42/Aβ40 ratio), hyperphosphorylated tau (P‐tau), neuronal injury/degeneration (T‐tau, NFL, NSE, H‐FABP, VILIP‐1), neuroinflammation biomarkers (YKL‐40, TREM2), and α‐synuclein (α‐synuclein). Associations between these biomarkers and age as well as apolipoprotein E ( APOE ) ε4 status were evaluated, and the associations among biomarkers were assessed. CSF Aβ42, P‐tau, and T‐tau levels exhibited nonlinear associations with age, among which Aβ42 was significantly modulated by APOE ε4 status. Specifically, an accelerated decline in Aβ42 levels occurred at 45.69 years of age in the APOE ε4+ group, which was almost 23 years earlier than that in the APOE ε4− group (68.02 years). The age‐related change pattern of CSF P‐tau is similar to that of T‐tau, with both increasing slightly with age but showing an accelerated change at ≈60 years of age in the APOE ε4+ group. All the other biomarkers except for α‐synuclein were linearly associated with age, and APOE ε4 status had no effect on these associations. Most biomarkers were positively correlated with each other except for Aβ42/Aβ40 ratio. The evolution of AD‐related biomarkers in CSF varies throughout the adult lifespan, with the APOE ε4 allele modifying the temporal changes in CSF Aβ42 levels, as well as potentially influencing P‐tau and T‐tau levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersAlzheimer DiseaseAgingCognitionHumansMiddle AgedMaleFemaleAgedAdultAged, 80 and overAmyloid beta-PeptidesYoung AdultAdolescenttau ProteinsApolipoprotein E4Peptide Fragments

Stichwörter der Autor:innen

APOE ε4Alzheimer's diseaseAβagingbiomarkerscerebrospinal fluidtautrajectory

Substanzen

BiomarkersAmyloid beta-Peptidestau ProteinsApolipoprotein E4Peptide Fragments

Autor:innen und Institutionen

  • Department of Neurology and Centre for Clinical Neuroscience, Daping Hospital, Third Military Medical University, Chongqing, China.
  • Department of Neurology, The General Hospital of Western Theater Command, Chengdu, China.
  • Department of Plateau Diseases, Shigatse Branch, Xinqiao Hospital, Third Military Medical University, Shigatse, China.
  • Department of Anesthesiology, Daping Hospital, Third Military Medical University, Chongqing, China.
  • Department of Neurosurgery, The General Hospital of Western Theater Command, Chengdu, China.
  • Chongqing Key Laboratory of Aging and Brain Diseases, Chongqing, China.

Förderung

  • Joint Fund of Chongqing Health Commission and Chongqing Science and Technology Bureau
  • National Key Research and Development Program of China

Zitieren

APA

Li, W. W., Fan, D. Y., Sun, Q., Wang, L. K., Huang, B. Q., Yu, Z. Y., Tian, D. Y., Shen, Y. Y., Tan, C. R., Zeng, G. H., Zeng, F., Fan, J., Wang, Z., Wang, Y. J., & Wang, J. (2025). Temporal Changes in Alzheimer's Disease‐Related Biomarkers in the CSF of Cognitively Normal Subjects at Different Ages: The Chongqing Ageing and Dementia Study. Aging Cell. https://doi.org/10.1111/acel.70036

Vancouver

Li WW, Fan DY, Sun Q, Wang LK, Huang BQ, Yu ZY, et al. Temporal Changes in Alzheimer's Disease‐Related Biomarkers in the CSF of Cognitively Normal Subjects at Different Ages: The Chongqing Ageing and Dementia Study. Aging Cell. 2025. doi:10.1111/acel.70036

BibTeX
@article{Li2025,
  author = {Li, Wei-Wei and Fan, Dong-Yu and Sun, Qi and Wang, Lei-Kai and Huang, Bing-Qiang and Yu, Zhong-Yuan and Tian, Ding-Yuan and Shen, Ying-Ying and Tan, Cheng-Rong and Zeng, Gui-Hua and Zeng, Fan and Fan, Jin and Wang, Zhen and Wang, Yan-Jiang and Wang, Jun},
  title = {Temporal Changes in Alzheimer's Disease‐Related Biomarkers in the CSF of Cognitively Normal Subjects at Different Ages: The Chongqing Ageing and Dementia Study},
  journal = {Aging Cell},
  year = {2025},
  doi = {10.1111/acel.70036}
}
Kostenlos starten →